Oral Or Mouth Cancer Treatment Hospital in Delhi

Important: Fuda Cancer Hospital is based in China. In India, Fuda has consultation centres (Mumbai & Noida). Rekosh Health Care is the India partner that coordinates bookings, report review and follow-up for Indian patients. Use Rekosh Health Care as your single contact point to start the care process.

Cancer treatment without surgery — what it means

“Non-surgical” (or minimally invasive) cancer care refers to treatments that avoid open operative procedures. These approaches include targeted systemic medicines, precise radiation, image-guided interventional procedures, local ablation techniques performed percutaneously, and supportive palliative care. The goal is to control or eliminate the tumor while reducing recovery time and preserving quality of life.

Why patients choose non-surgical routes

Common reasons patients look for non-surgical options:

• To avoid a major operation because of medical risks or comorbidities
• To preserve organ function (e.g., avoid removing part of an organ)
• When tumors are in locations that make surgery difficult or risky
• To reduce hospital stay and speed recovery
• When a combination of local and systemic treatments can control disease effectively

Non-surgical treatment categories — simple guide

Treatment selection depends on cancer type, stage, tumor location, prior treatments and overall health. Below are major non-surgical approaches used at Fuda.

1. Precision radiation therapies

• External beam radiotherapy (EBRT): Conventional, fractionated radiation delivered to the tumor while sparing normal tissue.
• Stereotactic body radiotherapy (SBRT) / Stereotactic radiosurgery (SRS): Very high-dose, highly focused radiation in few sessions — commonly used for small lung, liver, spine and brain lesions.
• Intensity-modulated radiotherapy (IMRT) & image-guided radiotherapy (IGRT): Advanced techniques that shape the dose to the tumor and protect critical organs.
• Brachytherapy: Internal radiation placed close to or inside the tumor for high local dose with limited exposure to surrounding tissue.

2. Systemic (non-surgical) medical therapies

• Targeted therapy: Drugs that act on specific genetic or molecular drivers in cancer cells (e.g., kinase inhibitors).
• Immunotherapy: Treatments that stimulate the immune system to recognise and kill cancer cells (e.g., checkpoint inhibitors, cell therapies where applicable).
• Hormonal therapy: Used for hormone-sensitive cancers (breast, prostate) to control growth without surgery.
• Chemotherapy (selective use): While this page focuses on non-surgical options, systemic chemotherapy may be used alone or in combination where needed; Fuda tailors treatment to minimise systemic toxicity.

3. Image-guided interventional procedures (minimally invasive, non-open)

• Radiofrequency Ablation (RFA) / Microwave Ablation: Percutaneous probes heat and destroy tumors — commonly used for liver, lung and kidney lesions.
• Irreversible Electroporation (NanoKnife / IRE): Non-thermal electrical pulses that destroy tumor cells—useful near nerves and blood vessels.
• Cryoablation: Freezing probes destroy tumor tissue with minimal bleeding and short recovery.
• Transarterial therapies (TACE, TARE): Catheter-based approaches deliver drugs or radioactive particles directly into a tumor’s blood supply (widely used for liver cancers).
• Percutaneous chemo-ablation: Local delivery of anti-cancer drugs directly into the tumor to minimise systemic exposure.

4. Combined and organ-preserving strategies

Many patients receive multimodal plans that combine radiation, targeted or immune therapy and image-guided interventions to maximise tumor control while avoiding open surgery. Fuda’s “3C+P” style models combine local control, targeted medicine and immune support when appropriate.

5. Supportive, rehabilitative and palliative care

• Pain management, symptom control, nutrition and physiotherapy to maintain quality of life.
• Palliative radiotherapy or minimally invasive procedures to relieve symptoms (e.g., pain, bleeding, obstruction).
• Psychological support and survivorship planning.

Who may be suitable for non-surgical treatment?

Each case is individual. Candidates frequently include:

• Patients with small, well-defined tumors treatable with SBRT or ablation
• Patients medically unfit for open surgery due to other health problems
• Those wishing to preserve organ function and avoid major resections
• Patients with metastatic disease where systemic therapy plus local control provides benefit

Fuda’s multidisciplinary teams review scans, pathology and prior treatments to recommend the safest, evidence-based plan.

How Indian patients can start

1. Contact Rekosh Health Care to book an online consultation with Fuda specialists. Rekosh coordinates bookings, report review and follow-up.
2. Share medical records: biopsy, CT/MRI/PET, blood work and treatment history.
3. Fuda’s team provides a tailored plan — often with non-surgical options or combined approaches when appropriate.
4. If a procedure or radiation is recommended, plan a visit to Fuda’s consultation centres in Noida or Mumbai, or follow their guidance for coordination of local care.
5. After treatment, Rekosh and Fuda assist with follow-up, rehabilitation and palliative support to optimise recovery.

Cost guide (approximate)

Costs depend heavily on diagnosis, tests, the number of treatment sessions and length of stay. These ranges (INR) are indicative only:

Treatment (non-surgical)	Approx Range (INR)
Stereotactic Body Radiotherapy (SBRT / SRS)	₹1,50,000 – ₹6,00,000
External Beam Radiotherapy (IMRT / IGRT)	₹50,000 – ₹3,00,000
Targeted therapy / Oral targeted drugs (per cycle/month variable)	₹50,000 – ₹5,00,000+
Immunotherapy (per dose / cycle)	₹75,000 – ₹5,00,000+
RFA / Microwave Ablation / Cryoablation	₹1,00,000 – ₹6,00,000
TACE / Radioembolization (TARE)	₹1,50,000 – ₹8,00,000
Brachytherapy	₹1,00,000 – ₹4,00,000

Prices vary by case complexity, imaging, anesthesia, hospital stay and drugs. Fuda and Rekosh will provide a written estimate after review.

Safety and outcomes

Non-surgical techniques are widely used and can be very effective when selected appropriately. Outcomes depend on cancer type, stage and patient factors. Fuda’s multidisciplinary approach aims to match the right non-surgical tools to each patient for the best balance of tumor control and quality of life.

Final words — discuss options with specialists

If you want to avoid open surgery, many modern non-surgical options exist — from precision radiotherapy and immunotherapy to image-guided ablations and arterial therapies. The first step is a professional review of your medical records so a personalised, evidence-based plan can be recommended.

Disclaimer: This page is informational and not a substitute for individual medical advice. Treatment decisions should be made together with qualified oncologists and the treating team.